Correlation Between DiaMedica Therapeutics and Generation Bio
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Generation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Generation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Generation Bio Co, you can compare the effects of market volatilities on DiaMedica Therapeutics and Generation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Generation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Generation Bio.
Diversification Opportunities for DiaMedica Therapeutics and Generation Bio
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between DiaMedica and Generation is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Generation Bio Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Generation Bio and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Generation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Generation Bio has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Generation Bio go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Generation Bio
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.34 times more return on investment than Generation Bio. However, DiaMedica Therapeutics is 1.34 times more volatile than Generation Bio Co. It trades about 0.1 of its potential returns per unit of risk. Generation Bio Co is currently generating about -0.3 per unit of risk. If you would invest 439.00 in DiaMedica Therapeutics on September 25, 2024 and sell it today you would earn a total of 98.50 from holding DiaMedica Therapeutics or generate 22.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Generation Bio Co
Performance |
Timeline |
DiaMedica Therapeutics |
Generation Bio |
DiaMedica Therapeutics and Generation Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Generation Bio
The main advantage of trading using opposite DiaMedica Therapeutics and Generation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Generation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will offset losses from the drop in Generation Bio's long position.DiaMedica Therapeutics vs. Fate Therapeutics | DiaMedica Therapeutics vs. Caribou Biosciences | DiaMedica Therapeutics vs. Arcus Biosciences | DiaMedica Therapeutics vs. Karyopharm Therapeutics |
Generation Bio vs. Fate Therapeutics | Generation Bio vs. Caribou Biosciences | Generation Bio vs. Arcus Biosciences | Generation Bio vs. Karyopharm Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements |